Abstract
Antimetabolites of purine metabolism have found a use as anti-leukaemic, antiprotozoal and antiviral drugs, in immunosuppression and transplantation, and in gout and hyperuricemia. Their mechanisms of action are reviewed.
References
Wood, D. D. (1940).Brit. J. Exp. Pathol. 21: 74.
Fildes, P. (1940)Lancet 1:955.
Hitchings, G. H., Elion, G. B., Falco, E. A., Russell, P. B., Sherwood, M. B. and Vander Werff, H. (1950)J. Biol. Chem. 183:1.
Hitchings, G. H., Elion G. B., Falco, E. A. Russell, P. B. and VanderWerff, H. (1950)Ann. NY Acad. Sci. 52:1318.
Kalckar, H. M. (1947)J. Biol. Chem. 167:461.
Hitchings, G. H. and Falco, E. A. (1944)Proc. Natl. Acad. Sci. USA 30:294.
Lorz, D. C. and Hitchings, G. H. (1950)Fed. Proc. 9:197.
Angier, R. B., Boothe, J. H. and Hutchings, B. L. et al. (1946)Science 103, 667.
Hitchings, G. H., Falco, E. A. and Sherwood, M. B. (1945)Science 102:251.
Elion, G. B. and Hitchings, G. H. (1950)J. Biol. Chem. 185:651.
Hitchings, G. H., Elion, G. B., VanderWerff, H. and Falco, E. A. (1948)J. Biol. Chem. 174:765.
Hitchings, G. H., Elion, G. B. and VanderWerff, H. (1948)J. Biol. Chem. 174:1037.
Carrington, H. C. (1944)J. Chem. Soc. 124.
Elion, G. B., Burgi, E. and Hitchings, G. H. (1952)J. Am. Chem. Soc. 74:411.
Elion, G. B. and Hitchings, G. H. (1950)J. Am. Chem. Soc. 77:1676.
Elion, G. B. and Hitchings, G. H. (1950)J. Biol. Chem. 187:511.
Elion, G. B., VanderWerff, H., Hitchings, G. H., Balis, M. E., Levin, D. H. and Brown, J. B. (1953)J. Biol. Chem. 200:7.
Kornberg, A., Lieberman, I. and Simms, E. S. (1955)J. Biol. Chem. 215:417.
Burchenal, J. H., Bendich, A., Brown, J. B., Elion, G. B., Hitchings, G. H., and Rhoads, C. P. et al. (1949)Cancer 2:119.
Biesele, J. J., Berger, R. E., Wilson, A. Y., Hitchings G. H. and Elion, G. B. (1951)Cancer 4:186.
Burchenal, J. H., Karnofsky, D. A. and Kingsley-Pillers, E. M. et al. (1951).Cancer 4:549.
Thompson, R. L., Wilkin, M. L., Hitchings, G. H., Elion, G. B., Falco, E. A. and Russell, P. B. (1949)Science 110:454.
Thompson, R. L., Price, M. L. Menton, S. A. jr., Elion, G. B. and Hitchings, G. H. (1950)J. Immunol. 65:529.
Elion, G. B., Hitchings, G. H. and VanderWerff, H. (1951)J. Biol. Chem. 192:505.
Clarke, D. A., Phillips, F. S., Sternberg, S. S., Stock, C. C. Elion, G. B. and Hitchings, G. H. (1953)Cancer Res. 13:593.
Philips, F. S. Sternberg, S. S. Hamilton, L. and Clarke, D. A. (1954)Ann. N.Y. Acad. Sci. 60:283.
Burchenal, J. H., Murphy, M. L. and Ellison, R. R. et al. (1953)Blood 8: 965.
6-Mercaptopurine, Ed. Rhoads, C. P. (1954)Ann N. Y. Acad. Sci. 60:183.
Elion, G. B., Singer, S. and Hitchings, G. H. (1954)Ann. N.Y. Acad. Sci. 60:200.
Elion, G. B., Singer, S. and Hitchings, G. H. (1953)J. Biol. Chem. 204:35.
Balis, M. E., Levin, D. H., Brown, G. B., Elion, G. B., Nathan, H. C. and Hitchings, G. H. (1957)Arch. Biochem. Biophys. 71:358.
Greenberg, G. R. and Jaenicke, L. (1957) In:The Chemistry and Biology of Purines (Ed. G. E. W. Wolstenholme and C. M. O'Connor) Churchill, London, pp. 204–232.
Buchanan, J. M., Flaks, J. G., Hartman, R. C., Levenberg, B. Lukens, L. N. and Warren, L. (1957) In:The Chemistry and Biology of Purines (Ed. G. E. W. Wolstenholme and C. M. O'Connor) Churchill, London, pp. 233–252.
Buchanan, J. B. and Hartman, S. C. (1959)Adv. Enzymol. 21:199.
Hitchings, G. H. and Elion, G. B. (1972) In:Cancer Chemotherapy II, Twenty-Second Hahnemann Symposium, (Ed. I. Brodsky, S. B. Kahn and J. H. Moyer) Grune and Stratton, New York, pp. 23–32.
Elion, G. B. (1975) In:Pharmacological Basis of Cancer Chemotherapy (Williams and Wilkins, Baltimore, pp. 547–564.
Elion, G. B., Bieber, S. and Hitchings, G. H. (1954)Ann. N.Y. Acad. Sci. 60:297.
Hamilton, L. and Elion, G. B. (1954)Ann. N.Y. Acad. Sci. 60:304.
Elion, G. B. (1957)Proc. Royal Soc. Med. 50:7.
Clarke, D. A., Elion, G. B., Hitchings, G. H. and Stock, C. C. (1958)Cancer Res. 18:445.
Elion, G. B., Goodman, I., Lange, W. and Hitchings, G. H. (1959)J. Am. Chem. Soc. 81:1898.
Elion, G. B., Bieber, S. and Hitchings, G. H. (1960)Cancer Chemother. Rep. 8:36.
Elion, G. B., Callahan, S. W. Hitchings, G. H. and Rundles, R. W. (1960)Cancer Chemother. Rep. 8:47.
Elion, G. B., Callahan, S. W. Hitchings, G. H. and Rundles, R. W. In:Proc. VIIIth International Congress Hematology, Vol I (Pan-Pacific Press, Tokyo, 1961) pp. 642–645.
Elion, G. B., Mueller, S. and Hitchings, G. H. (1959)J. Am. Chem. Soc. 81:3042.
Elion, G. B., Callahan, S., Rundles, R. W. and Hitchings, G. H.. (1963)Cancer Res. 23:1207.
Elion, G. B. (1967).Fed. Proc. 26:898.
deMiranda, P., Beacham III, L. M., Creagh, T. H. and Elion, G. B. (1973)J. Pharmacol. Exp. Ther. 187:588.
Elion, G. B. and Hitchings, G. H. (1975) In:Antineoplastic and Immunosuppressive Agents, Handbook of Experimental Pharmacology, Vol. 38/2, (Ed. A. C. Sartorelli and D. G. Jones) Springer-Verlag, Berlin, pp. 404–425.
deMiranda, P., Beacham III, L. M., Creagh T. H. and Elion, G. B. (1975)J. Pharmacol. Exp. Ther. 195:50 (1975).
Elion, G. B., Callahan, S. Bieber, S. and Rundles, R. W. (1961)Cancer Chemother. Rep. 14:93.
Rundles, R. W., Laszlo, J., Itoga, T., Hobson, G. B. and Garrison, F. E. Jr., (1961)Cancer Chemother. Rep. 14:99.
Schwartz, R. Stack, J. and Dameshek, W. (1958)Proc. Soc. Exp. Biol. Med. 99:164.
Chanmougan, D. and Schwartz, R. S. (1966)J. Exp. Med. 124:363.
Schwartz, R. and Dameshek, W. (1959)Nature 183:1682.
Nathan, H. C., Bieber, S. Elion, G. B. and Hitchings, G. H. (1961)Proc. Soc. Exp. Biol. Med.,107:796.
Bieber, S., Elion, G. B., Hitchings, G. H., Hooper, D. C. and Nathan, H. C. (1962)Proc. Soc. Exp. Biol. Med. 111:334.
Calne, R. Y. (1960)Lancet I:417.
Calne, R. Y.Transport Bull. (1961)28:65.
Calne, R. Y., Alexandre, G. P. J. and Murray, J. E. (1962)Ann. N.Y. Acad. Sci. 99: 743.
Murray, J. E., Merrill, J. P., Harrison, J. H., Wilson, R. E. and Dammin, G. J. (1963)N. Engl. J. Med. 268:1315.
The Twelfth Report of the Human Renal Transplant Registry, Advisory Committee to the Renal Transplant Registry, (1975)J. Am. Med. Assoc. 233:787.
Perdue, S. T., Terasaki, P. I., Cats, S. and Mickey, M. R. (1983)Transplantation 36:658.
Takiff, H., Cook, D. J., Himaya, N. S. Mickey, M. R. and Terasaki, P. I. (1988).Transplantation 45:410.
Hitchings, G. H. and Elion, G. B. (1963)Pharmacol. Rev. 15:365.
Wolberg, G. In:Pharmacology of Lymphocytes Handbook of Experimental Pharmacology, Vol. 85, Ed. M. A. Bray and J. Morley (Springer-Verlag, Berlin, 1988) pp. 517–533.
Hunter, T., Urowitz, M. B. Gordon, D. A. Smythe, H. A. and Ogryzlo, M. A. (1975)Arthritis Rheum. 18:15.
Elion, G. B., Callahan, S. W., Hitchings, G. H., Rundles, R. W. and Laszlo, J. (1962)Cancer Chemother. Rep. 16:197.
Elion, G. B., Callahan, S., Nathan, H., Bieber, S., Rundles, R. W. and Hitchings, G. H. (1963)Biochem. Pharmacol. 12:85.
Rundles, R. W., Wyngaarden, J. B., Hitchings, G. H., Elion, G. B. and Silberman, H. R. (1963)Trans. Assoc. Am. Physicians 76:126.
Rundles, R. W. (1966)Ann. Rheum. Dis. 25:615.
Hitchings, G. H. and Elion, G. B. (1985)Cancer Res. 45:2415.
Vogler, W. R., Bain, J. A., Huguley, C. M. Jr., Palmer, H. G. Jr. and Lowrey, M. E. (1966)Am. J. Med. 40:548.
Hitchings, G. H. (1966)Ann. Rheum. Dis. 25:601.
Symposium on Allopurinol, Ed. J. T. Scott, (1966)Ann. Rheum. Dis. 25:599.
Elion, G. B. (1966)Ann. Rheum. Dis. 25:608.
Massey, V., Komai, H., Palmer, G. and Elion, G. B. (1970)J. Biol. Chem. 245: 2837.
Massev, V., Komai, H., Palmer, G. and Elion, G. B. (1970)Vitam. Horm. 28: 505.
Elion, G. B., Kovensky, A., Hitchings, G. H., Metz, E. and Rundles, R. W. (1966)Biochem. Pharmacol. 15:863.
Elion, G. B. In:Uric Acid. Handbook of Experimental Pharmacology, Vol. 51, Ed. W. N. Kelley and I. M. Wiener (Springer-Verlag, Berlin, 1978) pp. 485–514.
Elion, G. B., Yü, T.-F., Gutman, A. B. and Hitchings, G. H. (1968)Am. J. Med. 45:69.
Yü, T. F. and Gutman, A. B. (1964)Am. J. Med. 37:885.
Pomales, R., Bieber, S., Friedman, R. and Hitchings, G. H. (1963)Biochim. Biophys. Acta. 72:119.
Pomales, R., Elion, G. B. and Hitchings, G. H. (1965)Biochim. Biophys. Acta. 95:505.
Wyngaarden, J. B. and Ashton, D. M. (1959)J. Biol. Chem. 234:1492.
Goldfinger, S., Klinenberg, J. R. and Seegmiller, J. E. (1965)J. Clin. Invest. 44: 623.
Klinenberg, J. R., Goldfinger, S. E. and Seegmiller, J. E. (1965)Ann. Intern. Med. 62: 639.
Rundles, R. W. (1985)Arch. Intern. Med. 145:1492.
Elion, G. B., Benezra, F. M., Beardmore, T. D. and Kelley, W. N. In:Purine Metabolism in Man IIIA Ed. A. Rapado, R. W. E. Watts and C. H. M. M. DeBruyn (Plenum, New York, 1980) pp. 263–267.
Rundles, R. W., Metz, E. and Silberman, H. R. (1966)Ann. Intern. Med. 64:229.
deVries, A., Frank, M., Liberman, U. A. and Sperling, O. (1966)Ann. Rheum. Dis. 25:691.
Krakoff, I. H. (1965)Arthritis Rheum. 8:896.
Pfaller, M. A. and Marr, J. J. (1974)Antimcrob. Agents. Chemother. 5:469.
Nelson, D. J., Bugge, C. J. I., Elion, G. B.., Berens, R. L. and Marr. J. J. (1979)J. Biol. Chem. 254:3959.
Nelson, D. J., LaFon, S. W. and Tuttle, J. V. et al., (1979)J. Biol. Chem. 254:11544.
Marr, J., Berens, R. and Nelson, D. (1978)Science 201:1018.
Spector, T., Jones, T. E. and Elion, G. B. (1979)J. Biol. Chem. 254:8422.
Krenitsky, T. A., Koszalka, G. W., Tuttle, J. V., Adamcyzk, D. L., Elion, G. B. and Marr, J. J. In:Purine Metabolism in Man IIIB Ed. A Rapado, R. E. Watts and C. H. M. M. DeBruyn (Plenum, New York, 1980) pp. 271–276.
Berens, R. L., Marr, J. J., Nelson, D. J. and LaFon, S. W. (1980)Biochem. Pharmacol. 29:2397.
LaFon, S. W., Nelson, D. J., Berens, R. L. and Marr, J. J. (1982)Biochem. Pharmacol. 31:231.
Berens, R. L., Marr, J. J., Steele De Cruz F. and Nelson, D. J. (1982)Antimicrob. Agents. Chemother. 22:657.
Spector, T., Berens, R. L. and Marr, J. J. (1982)Biochem. Pharmacol. 31:225.
Nelson, D. J. and Elion, G. B. (1975)Biochem. Pharmacol. 24:1235.
Kager, P. A., Rees, P. H. and Wellde, B. T. et al., (1981)Trans. R. Soc. Trop. Med. Hyg. 75:556.
Meirovich, C. I., Montrull, H. L., Gallerano, R. H. and Sosa, R. R. (1985)Arq. Bras. Cardiol. 45:217.
Schabel, F. M. Jr., (1968)Chemotherapy 13:321.
Elion, G. B., Rideout, J. L., deMiranda, P., Collins, P. and Bauer, D. J. (1975)Ann. N.Y. Acad. Sci. 255:468.
Schaeffer, H. J., Gurwara, S., Vince, R. and Bittner, S. (1971)J. Med. Chem. 14:367.
Elion, G. B., Furman, P. A., Fyfe, J. A., deMiranda, P., Beauchamp, L. and Schaeffer, H. J. (1977)Proc. Natl. Acad. Sci. U.S.A. 74:5716.
Schaeffer, H. J., Beauchamp, L., deMiranda, P., Elion, G. B., Bauer, D. J. and Collins, P. (1978)Nature 272:583.
Good, S. S. and DeMiranda, P. (1982)Fed. Proc. 41:1733.
Krasny, H. C., Liao, S. H. T., Good, S. S., Petty, B. and Lietman, P. S. (1983)Clin. Pharmacol. Ther. 33:256.
Spector, T., Jones, T. E. and Beacham, L. M. III, (1983)Biochem. Pharmacol. 32: 2505.
Elion, G. B. (1982)Am. J. Med. 73(1A):7.
Collins, P. (1983)J. Antimicrob. Chemother. 12(Suppl. B):19.
Elion, G. B. (1983)J. Antimicrob. Chemother. 12(Suppl. B):9.
Fyfe, J. A., Keller, P. M., Furman, P. A., Miller, R. L. and Elion, G. B. (1978)J. Biol. Chem. 253:8721.
Miller, W. H. and Miller, R. L. (1980)J. Biol. Chem. 255:7204.
Miller, W. H. and Miller, R. L. (1982)Biochem. Pharmacol.,31:3879.
Furman, P. A., deMiranda, P., St. Clair, M. H. and Elion, G. B. (1981)Antimicrob. Agents Chemother. 20:518.
Keller, P. M., McKee, S. A. and Fyfe, J. A. (1985)J. Biol. Chem. 260:8664.
Furman, P. A., St. Clair, M. H., Fyfe, J. A., Rideout, J. L., Keller, P. M. and Elion, G. B. (1979)J. Virol. 32:72.
St. Clair, M. H., Furman, P. A., Lubbers, C. M. and Elion G. B. (1980)Antimicrob. Agents Chemother. 18:741.
Elion, G. B. (1986) In:Antiviral Chemotherapy: New Directions for Clinical Application and Research, (Ed. J. Mills and L. Corey) Elsevier, New York, pp. 118–137.
McGuirt, P. V., Shaw, J. E., Elion, G. B. and Furman, P. a. (1984)Antimicrob. Agents. Chemother. 25:507.
Furman, P. A., St. Clair, M. H. and Spector, T. (1984)J. Biol. Chem. 259:9575.
Keller, P. M., Fyfe, J. A. and Beauchamp, L. et al., (1981)Biochem. Pharmacol. 30: 3071.
Schnipper, L. E. and Crumpacker, C. S. (1980)Proc. Natl. Acad. Sci. U.S.A. 77:2270.
Furman, P. A., ooen, D. M., St. Clair, M. H. and Schaffer, P. A. (1981)J. Virol. 40:936.
Biron, K. K., Fyfe, J. A., Noblin, J. E. and Elion, G. B. (1982)Am. J. Med. 73(1A):383.
Furman, P. A., McGuirt, P. V., Keller, P. M., Fyfe, J. A. and Elion G. B. (1980)Virology 102:420.
Pagano, J. S., Sixbey, J. W. and Lin, J.-C. (1983)J. Antimicrob. Chemother. 12 (Suppl. B):113.
Ashton, W. T., Karkas, J. D., Field, A. K. and Tolman, R. L. (1982)Biochem. Biophys. Res. Commun. 108:1716.
Cheng, Y. C., Grill, S. P., Dutschman, G. E., Narayama, K. and Bastow, K. F. (1983)J. Biol. Chem. 258:12460.
Biron, K. K., Stanat, S. C. and Sorrell, J. B. et al. (1985)Proc. Natl. Acad. Sci. U.S.A. 82:2473.
deMiranda, P., Krasny, H. C., Page, D. A. and Elion, G. B. (1981)J. Pharmacol. Exp. Ther. 219:309.
deMiranda, P., Good, S. S. Laskin, O. L., Krasny, H. C., Connor, J. D. and Lietman, P. S. (1981)Clin. Pharmacol. Ther. 30:662.
deMiranda, P., Good, S. S. Kransy, H. C., Connor, J. D., Laskin, O. L. and Lietman, P. S. (1982)Am. J. Med. 73(1A):215.
Good, S. S. and deMiranda, P. (1982)Am. J. Med. 73(1A):91.
deMiranda, P., Whitley, R. J. and Blum, M. R. et al. (1979)Clin. Pharmacol. Ther. 26:718.
deMiranda, P. and Blum, M. R. (1983)J. Antimicrob. Chemother. 12(Suppl. B):29.
Blum, M. R., Liao, S. H. T. and deMiranda, P. (1982)Am. J. Med. 73(1A):186.
Tucker, W. E. (1982)Am. J. Med. 73(1A):27.
Elion, G. B. (1985)Cancer Res. 45:2943.
Corey, L., Benedetti, J. and Critchlow, C. et al. (1983)J. Antimicrob. Chemother. 12 (Suppl. B):79.
Nilsen, A. E., Aesen, T. and Halsos, A. M. et al. (1982)Lancet 2:571.
Bryson, Y. J., Dillon, M. and Lovett, M. et al. (1983)N. Engl. J. Med. 308:916.
Reichman, R. C., Badger, G. J. and Mertz, D. C. et al. (1984)J. Am. Med. Assoc. 251: 2103.
Mertz, G. J., Eron, L. and Kaufman, R. et al. (1988)Am. J. Med. 85(2A): 14.
Mattison, H. R., Reichman, R. C. and Benedetti, J. et al. (1988)Am. J. Med. 85 (2A):20.
Bean, B. and Braun, C. (1982)Lancet 2:118.
Balfour, H. H., McMonigal, K. A. and Bean, B. (1983)J. Antimicrob. Chemother. 12 (Suppl. B):169.
Meyers, J. D., Wade, J. C. and Mitchell, C. D. et al. (1982)Am. J. Med. 73 (1A):229.
Wade, J. C., Newton, B. and McLaren, C. et al. (1982)Ann. Intern. Med. 96:265.
Saral, R., Burns, W. H., Laskin, O. L. et al. (1981)N. Engl. J. Med. 305:63.
Saral, R., Ambinder, R. F., Burns, W. H., et al. (1983)Ann. Intern. Med. 99:773.
Sköldenberg, B., Forsgren, M., Alestig, K. et al. (1984)Lancet 2:707.
Whitley, R. J., Alford, C. A., Hirsch, M. S. et al. (1986)N. Engl. J. Med. 314: 144.
Author information
Authors and Affiliations
Additional information
Nobel Lecture given on December 8, 1988; by Dr Gertrude B. Elion and published inLes Prix Nobel 1988, printed in Sweden by Norstedts Tryckeri, Stockholm, Sweden, 1989, republished here with the permission of the Nobel Foundation, the copyright holder.
Rights and permissions
About this article
Cite this article
Elion, G.B. The purine path to chemotherapy. Biosci Rep 9, 509–529 (1989). https://doi.org/10.1007/BF01119794
Issue Date:
DOI: https://doi.org/10.1007/BF01119794